[go: up one dir, main page]

WO2009138752A3 - Vaccin pour poisson - Google Patents

Vaccin pour poisson Download PDF

Info

Publication number
WO2009138752A3
WO2009138752A3 PCT/GB2009/001215 GB2009001215W WO2009138752A3 WO 2009138752 A3 WO2009138752 A3 WO 2009138752A3 GB 2009001215 W GB2009001215 W GB 2009001215W WO 2009138752 A3 WO2009138752 A3 WO 2009138752A3
Authority
WO
WIPO (PCT)
Prior art keywords
fish
shellfish
fin
disease
aquatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2009/001215
Other languages
English (en)
Other versions
WO2009138752A2 (fr
Inventor
John Bernard March
Jason Richard Clark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BigDNA Ltd
Original Assignee
BigDNA Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BigDNA Ltd filed Critical BigDNA Ltd
Publication of WO2009138752A2 publication Critical patent/WO2009138752A2/fr
Publication of WO2009138752A3 publication Critical patent/WO2009138752A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2795/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Feed For Specific Animals (AREA)

Abstract

Les maladies virales et bactériennes chez les poissons à nageoires, les crustacés ou d’autres formes de vies aquatiques constituent un problème grave pour l’industrie de l’aquaculture. En raison de la forte densité d’animaux dans les réservoirs d’alevinage ou les zones d’élevage marin fermées, des maladies infectieuses peuvent éradiquer une proportion importante du stock, par exemple dans les installations de poissons à nageoires, de crustacés ou d’autres formes de vies aquatiques. Pour parer à ces menaces pour les poissons, la prévention des maladies constitue un remède plus souhaitable que l’intervention une fois la maladie déjà en cours de progression. La vaccination des poissons représente l’unique méthode préventive susceptible d’offrir une protection à long terme par l’immunité.
PCT/GB2009/001215 2008-05-15 2009-05-15 Vaccin pour poisson Ceased WO2009138752A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0808780.1A GB0808780D0 (en) 2008-05-15 2008-05-15 Fish vaccines
GB0808780.1 2008-05-15

Publications (2)

Publication Number Publication Date
WO2009138752A2 WO2009138752A2 (fr) 2009-11-19
WO2009138752A3 true WO2009138752A3 (fr) 2010-03-18

Family

ID=39571359

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2009/001215 Ceased WO2009138752A2 (fr) 2008-05-15 2009-05-15 Vaccin pour poisson

Country Status (2)

Country Link
GB (1) GB0808780D0 (fr)
WO (1) WO2009138752A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108103031A (zh) * 2018-01-10 2018-06-01 浙江省淡水水产研究所 一种水产养殖用宽谱噬菌体制剂及其制备方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101536901B1 (ko) * 2013-08-26 2015-07-15 군산대학교산학협력단 바실러스 서브틸러스 및 파지 혼합물을 유효성분으로 함유하는 어류용 프로바이오틱스 조성물
PL246657B1 (pl) 2016-04-03 2025-02-24 Proteon Pharmaceuticals Spolka Akcyjna Szczepy bakteriofagów i ich zastosowania

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180614B1 (en) * 1995-11-07 2001-01-30 Loeb Health Research Institute At The Ottawa Hospital DNA based vaccination of fish
WO2002076498A2 (fr) * 2001-03-23 2002-10-03 Moredun Research Institute Immunisation obtenue au moyen de bacteriophages
WO2003024481A2 (fr) * 2001-09-14 2003-03-27 Cytos Biotechnology Ag Emballage de substances immunnostimulatrices dans des particules de type virus : procede de preparation et utilisation correspondants
WO2004030694A1 (fr) * 2002-10-02 2004-04-15 Moredun Research Institute Immunisation contre l'hepatite utilisant la mediation de bacteriophages

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180614B1 (en) * 1995-11-07 2001-01-30 Loeb Health Research Institute At The Ottawa Hospital DNA based vaccination of fish
WO2002076498A2 (fr) * 2001-03-23 2002-10-03 Moredun Research Institute Immunisation obtenue au moyen de bacteriophages
WO2003024481A2 (fr) * 2001-09-14 2003-03-27 Cytos Biotechnology Ag Emballage de substances immunnostimulatrices dans des particules de type virus : procede de preparation et utilisation correspondants
WO2004030694A1 (fr) * 2002-10-02 2004-04-15 Moredun Research Institute Immunisation contre l'hepatite utilisant la mediation de bacteriophages

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
CLARK J R ET AL: "BACTERIAL VIRUSES AS HUMAN VACCINES?", EXPERT REVIEW OF VACCINES, FUTURE DRUGS, LONDON, GB, vol. 3, no. 4, 1 August 2004 (2004-08-01), pages 463 - 476, XP008050350, ISSN: 1476-0584 *
CLARK J R ET AL: "Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials", TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 24, no. 5, 1 May 2006 (2006-05-01), pages 212 - 218, XP025052284, ISSN: 0167-7799, [retrieved on 20060501] *
CLARK JASON R ET AL: "Bacteriophage-mediated nucleic acid immunisation", FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY,, vol. 40, no. 1, 15 January 2004 (2004-01-15), pages 21 - 26, XP002562512 *
JEPSON C D ET AL: "Bacteriophage lambda is a highly stable DNA vaccine delivery vehicle", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 22, no. 19, 23 June 2004 (2004-06-23), pages 2413 - 2419, XP004515458, ISSN: 0264-410X *
KURATH G ET AL: "Protective immunity and lack of histopathological damage two years after DNA vaccination against infectious hematopoietic necrosis virus in trout", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 24, no. 3, 16 January 2006 (2006-01-16), pages 345 - 354, XP025151080, ISSN: 0264-410X, [retrieved on 20060116] *
LORENZEN NIELS ET AL: "Immunity induced shortly after DNA vaccination of rainbow trout against rhabdoviruses protects against heterologous virus but not against bacterial pathogens", DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, vol. 26, no. 2, March 2002 (2002-03-01), pages 173 - 179, XP002563022, ISSN: 0145-305X *
MARCH J B ET AL: "Genetic immunisation against hepatitis B using whole bacteriophage lambda particles", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 22, no. 13-14, 16 April 2004 (2004-04-16), pages 1666 - 1671, XP004500420, ISSN: 0264-410X *
MARCH JOHN B: "Modern Vaccine Adjuvants and Delivery Systems-- Second International Conference: September 12-14 2006, London, UK", EXPERT REVIEW OF VACCINES, FUTURE DRUGS, LONDON, GB, vol. 5, no. 6, 1 December 2006 (2006-12-01), pages 753 - 759, XP009094234, ISSN: 1476-0584 *
NAKAI TOSHIHIRO ET AL: "Bacteriophage therapy of infectious diseases in aquaculture", RESEARCH IN MICROBIOLOGY, ELSEVIER, AMSTERDAM, NL, vol. 153, no. 1, 1 January 2002 (2002-01-01), pages 13 - 18, XP002401837, ISSN: 0923-2508 *
PURCELL M K ET AL: "Comprehensive gene expression profiling following DNA vaccination of rainbow trout against infectious hematopoietic necrosis virus", MOLECULAR IMMUNOLOGY, PERGAMON, GB, vol. 43, no. 13, 1 May 2006 (2006-05-01), pages 2089 - 2106, XP025037277, ISSN: 0161-5890, [retrieved on 20060501] *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108103031A (zh) * 2018-01-10 2018-06-01 浙江省淡水水产研究所 一种水产养殖用宽谱噬菌体制剂及其制备方法
CN108103031B (zh) * 2018-01-10 2021-09-07 浙江省淡水水产研究所 一种水产养殖用宽谱噬菌体制剂及其制备方法

Also Published As

Publication number Publication date
WO2009138752A2 (fr) 2009-11-19
GB0808780D0 (en) 2008-06-18

Similar Documents

Publication Publication Date Title
Johnson et al. “Vaccination” of shrimp against viral pathogens: phenomenology and underlying mechanisms
Mineur et al. Positive feedback loop between introductions of non‐native marine species and cultivation of oysters in Europe
WO2008128654A3 (fr) Utilisation de fongicides pour traiter des mycoses du poisson
Rodgers et al. A literature review as an aid to identify strategies for mitigating ostreid herpesvirus 1 in Crassostrea gigas hatchery and nursery systems
CN105557571A (zh) 一种立体生态混养模式联合防控肝胰腺坏死症和白斑综合症的方法
Can et al. Best practices for fish biosecurity, well-being and sustainable aquaculture
Buschmann et al. Challenges for future salmonid farming
CN102187833B (zh) 一种用斜带石斑鱼防控虾类传染性疾病的方法
WO2009138752A3 (fr) Vaccin pour poisson
Escobedo-Bonilla Application of RNA interference (RNAi) against viral infections in shrimp: a review
CN101107921A (zh) 无毒暗纹东方鲀家系养殖方法
Makhrov et al. Genetic methods for the control of alien species
JP5522395B2 (ja) 魚類の飼育方法
CN105994020A (zh) 一种抗刺激隐核虫斜带石斑鱼苗种的生产方法
JP5553337B2 (ja) 海産魚白点病予防治療剤
Naim Preliminary study on microbial activity associated with tilapia culture against Vibrio harveyi.
Yu et al. Larval, juvenile, and adult predators
CN107410114A (zh) 一种带鱼的驯养方法
CN105941194A (zh) 一种抗刺激隐核虫巨石斑鱼苗种的生产方法
Shaaban Evaluation of Disease Resistance in Selectively Bred Channel Catfish (Ictalurus punctatus) and Hybrid Catfish (Channel Catfish♀ x Blue Catfish (I. furcatus)♂)
Myskja et al. Changing an iconic species by biotechnology: The case of Norwegian salmon
CN102415343A (zh) 波纹唇鱼的一种海上网箱养殖技术
CN203827866U (zh) 一种中华绒螯蟹脱壳隐蔽装置
Brooks et al. The Impact of Biotechnology in Aquaculture and Marine Resources
Duggan Effects of introduced fish on zooplankton–fact sheet

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09746069

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09746069

Country of ref document: EP

Kind code of ref document: A2